We are live on ! Find out more
RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $810M
1-Year Est. Return 30.2%
This Fund
S&P 500
This Quarter Est. Return
+17.86%
1 Year Est. Return
+30.2%
3 Year Est. Return
+116.38%
5 Year Est. Return
+153.13%
10 Year Est. Return
+962.25%
AUM
$345M
AUM Growth
+$3.48M
Cap. Flow
-$46.4M
Cap. Flow %
-13.44%
Top 10 Hldgs %
30.53%
Holding
110
New
11
Increased
34
Reduced
36
Closed
26

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$13.9M
2
CELG
Celgene Corp
CELG
+$10.8M
3
RCPT
RECEPTOS INC COM STK (DE)
RCPT
+$5.32M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.74M
5
MDVN
MEDIVATION, INC.
MDVN
+$3.4M

Top Sells

Rank Stock Value
1
UHS icon
Universal Health Services
UHS
+$10.3M
2
MDT icon
Medtronic
MDT
+$6.86M
3
ALKS icon
Alkermes
ALKS
+$6.27M
4
INCY icon
Incyte
INCY
+$4.12M
5
NPSP
NPS PHARMACEUTICALS INC
NPSP
+$4.03M

Sector Composition

Rank Sector Weight
1 Healthcare 80.57%
2 Consumer Staples 1.97%
3 Financials 1.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CTRX
101
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
– –
-93,000
Closed -$3.92M
HPTX
102
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
– –
-80,369
Closed -$2.03M
CFN
103
DELISTED
CAREFUSION CORPORATION
CFN
– –
-45,000
Closed -$2.04M
VOLC
104
DELISTED
VOLCANO CORPORATION COM STK
VOLC
– –
-44,221
Closed -$470K
BCR
105
DELISTED
CR Bard Inc.
BCR
– –
-17,000
Closed -$2.43M
AGN
106
DELISTED
Allergan Inc
AGN
– –
-16,500
Closed -$2.94M
1 2 3 4
5

Similar funds

PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
ACM
Ashford Capital Management Wilmington, Delaware $809M AUM 35.1% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
BCM
Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return
RIM
Redwood Investment Management Scottsdale, Arizona $805M AUM 15.01% 1-Year Est. Return
GCM
Glendon Capital Management Santa Monica, California $805M AUM 17.91% 1-Year Est. Return
CL
CVFG LLC Shelbyville, Indiana $804M AUM 27.61% 1-Year Est. Return

Rhenman & Partners Asset Management's Q4 2014 Portfolio in Review

As of Q4 2014, Rhenman & Partners Asset Management held 110 positions worth $345M, up 1% from $342M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Rhenman & Partners Asset Management withdrew a net $46.4M in Q4 2014, closing 26 positions and reducing 36 holdings. Its most notable exit was Universal Health Services, an estimated $10.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 81% of assets, up from 79% a quarter earlier, followed by Consumer Staples and Financials.

Against the trend, Rhenman & Partners Asset Management opened a new position in RECEPTOS INC COM STK (DE) worth $6.43M.

  • Rhenman & Partners Asset Management's largest Q4 2014 buy was RECEPTOS INC COM STK (DE): 52,526 shares worth $6.43M.
  • Rhenman & Partners Asset Management added most to Gilead Sciences in Q4 2014, an estimated $13.9M increase.
  • Rhenman & Partners Asset Management's biggest Q4 2014 reduction was Medtronic, cutting an estimated $6.86M.
  • Rhenman & Partners Asset Management fully exited Universal Health Services in Q4 2014, selling an estimated $10.3M.
  • Rhenman & Partners Asset Management's ten largest holdings make up 31% of its $345M portfolio in Q4 2014.
  • Rhenman & Partners Asset Management opened 11 new positions and closed 26 in Q4 2014.
  • Rhenman & Partners Asset Management's portfolio value rose 1% quarter-over-quarter to $345M.

Based on Rhenman & Partners Asset Management's 13F filing for Q4 2014, filed 9 Feb 2015.